Advanced search
Publication Cover
Drug Delivery Volume 24, 2017 - Issue 1
Submit an article Journal homepage
2,378
Views
23
CrossRef citations to date
0
Altmetric
Research Article

Targeted inhibition of human hematological cancers in vivo by doxorubicin encapsulated in smart lipoic acid-crosslinked hyaluronic acid nanoparticles

Yinan Zhonga Biomedical Polymers Laboratory, and Jiangsu Key Laboratory of Advanced Functional Polymer Design and Application, College of Chemistry, Chemical Engineering and Materials Science, Soochow University, Suzhou, China; View further author information
,
Fenghua Menga Biomedical Polymers Laboratory, and Jiangsu Key Laboratory of Advanced Functional Polymer Design and Application, College of Chemistry, Chemical Engineering and Materials Science, Soochow University, Suzhou, China; Correspondence[email protected]
View further author information
,
Chao Denga Biomedical Polymers Laboratory, and Jiangsu Key Laboratory of Advanced Functional Polymer Design and Application, College of Chemistry, Chemical Engineering and Materials Science, Soochow University, Suzhou, China; View further author information
,
Xinliang Maob Department of Pharmacology, Jiangsu Key Laboratory of Translational Research and Therapy for Neuro-psycho-diseases, College of Pharmaceutical Sciences, Soochow University, Suzhou, Jiangsu, China; ;c Jiangsu Key Laboratory of Preventive and Translational Medicine for Geriatric Diseases, Soochow University, Suzhou, Jiangsu, ChinaCorrespondence[email protected]
View further author information
&
Zhiyuan Zhonga Biomedical Polymers Laboratory, and Jiangsu Key Laboratory of Advanced Functional Polymer Design and Application, College of Chemistry, Chemical Engineering and Materials Science, Soochow University, Suzhou, China; Correspondence[email protected]
View further author information
Pages 1482-1490 | Received 31 Aug 2017, Accepted 22 Sep 2017, Published online: 28 Sep 2017

Citations (23)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (3)

Yu Sakurai & Hideyoshi Harashima. (2019) Hyaluronan-modified nanoparticles for tumor-targeting. Expert Opinion on Drug Delivery 16:9, pages 915-936.
Read now
Dechun Huang, Hongliang Qian, Haishi Qiao, Wei Chen, Jan Feijen & Zhiyuan Zhong. (2018) Bioresponsive functional nanogels as an emerging platform for cancer therapy. Expert Opinion on Drug Delivery 15:7, pages 703-716.
Read now
Dongdong Bi, Lei Zhao, Runqi Yu, Haowen Li, Yifei Guo, Xiangtao Wang & Meihua Han. (2018) Surface modification of doxorubicin-loaded nanoparticles based on polydopamine with pH-sensitive property for tumor targeting therapy. Drug Delivery 25:1, pages 564-575.
Read now

Articles from other publishers (20)

Debora F. Silva, Ailime L. P. Melo, Ana F. C. Uchôa, Graziela M. A. Pereira, Alisson E. F. Alves, Maria C. Vasconcellos, Francisco H. Xavier-Júnior & Marcele F. Passos. (2023) Biomedical Approach of Nanotechnology and Biological Risks: A Mini-Review. International Journal of Molecular Sciences 24:23, pages 16719.
Crossref
Manpreet Bariana, Beilu Zhang, Jingyu Sun, Weiwei Wang, Jinping Wang, Elena Cassella, Faith Myint, Shaina A. Anuncio, Samedy Ouk, Hsiou-Chi Liou, Ming Tan, Hongjun Wang & Johannes L. Zakrzewski. (2023) Targeted Lymphoma Therapy Using a Gold Nanoframework-Based Drug Delivery System. ACS Applied Materials & Interfaces 15:5, pages 6312-6325.
Crossref
Micael G. Gouveia, Justus P. Wesseler, Jobbe Ramaekers, Christoph Weder, Philip B. V. Scholten & Nico Bruns. (2023) Polymersome-based protein drug delivery – quo vadis?. Chemical Society Reviews 52:2, pages 728-778.
Crossref
Danka Cholujova, Lenka Koklesova, Zdenka Lukacova Bujnakova, Erika Dutkova, Zuzana Valuskova, Patricia Beblava, Anna Matisova, Jan Sedlak & Jana Jakubikova. (2022) In vitro and ex vivo anti-myeloma effects of nanocomposite As4S4/ZnS/Fe3O4. Scientific Reports 12:1.
Crossref
Theodoros Karalis & Spyros S. Skandalis. (2022) Hyaluronan network: a driving force in cancer progression. American Journal of Physiology-Cell Physiology 323:1, pages C145-C158.
Crossref
Peipei Yang, Ying Qu, Mengyao Wang, Bingyang Chu, Wen Chen, Yuhuan Zheng, Ting Niu & Zhiyong Qian. (2022) Pathogenesis and treatment of multiple myeloma. MedComm 3:2.
Crossref
Hao Wu, Yuan Gao, Jia Ma, Maosong Hu, Jing Xia, Shuting Bao, Yuxi Liu & Kai Feng. (2022) Cytarabine delivered by CD44 and bone targeting redox-sensitive liposomes for treatment of acute myelogenous leukemia. Regenerative Biomaterials 9.
Crossref
Tianyuan Ci, Wentao Zhang, Yingyu Qiao, Huangjuan Li, Jing Zang, Hongjun Li, Nianping Feng & Zhen Gu. (2022) Delivery strategies in treatments of leukemia. Chemical Society Reviews 51:6, pages 2121-2144.
Crossref
Tetyana Ignatova, Sajedeh Pourianejad, Xinyi Li, Kirby Schmidt, Frederick Aryeetey, Shyam Aravamudhan & Slava V. Rotkin. (2022) Multidimensional Imaging Reveals Mechanisms Controlling Multimodal Label-Free Biosensing in Vertical 2DM-Heterostructures. ACS Nano 16:2, pages 2598-2607.
Crossref
Priyanka Samal & Shahani Begum. 2022. Advanced Nanomaterials for Point of Care Diagnosis and Therapy. Advanced Nanomaterials for Point of Care Diagnosis and Therapy 383 398 .
Theodoros T. Karalis & Spyros S. Skandalis. 2022. The Extracellular Matrix and the Tumor Microenvironment. The Extracellular Matrix and the Tumor Microenvironment 457 494 .
Wenxing Gu, Ruobing Qu, Fenghua Meng, Jeroen J.L.M. Cornelissen & Zhiyuan Zhong. (2021) Polymeric nanomedicines targeting hematological malignancies. Journal of Controlled Release 337, pages 571-588.
Crossref
Daniela Iannazzo, Roberta Ettari, Salvatore Giofrè, Ali H. Eid & Alessandra Bitto. (2020) Recent Advances in Nanotherapeutics for Multiple Myeloma. Cancers 12:11, pages 3144.
Crossref
Wenhao Zhong, Xinyu Zhang, Meng Zhao, Jun Wu & Dongjun Lin. (2020) Advancements in nanotechnology for the diagnosis and treatment of multiple myeloma. Biomaterials Science 8:17, pages 4692-4711.
Crossref
Xiuxiu Wang, Min Qiu, Chao Deng, Ru Cheng & Zhiyuan Zhong. (2019) Targeted and Reduction-Sensitive Cross-Linked PLGA Nanotherapeutics for Safer and Enhanced Chemotherapy of Malignant Melanoma. ACS Biomaterials Science & Engineering 6:5, pages 2621-2629.
Crossref
Yinan Zhong, Fenghua Meng, Wen Zhang, Bin Li, Jan C.M. van Hest & Zhiyuan Zhong. (2020) CD44-targeted vesicles encapsulating granzyme B as artificial killer cells for potent inhibition of human multiple myeloma in mice. Journal of Controlled Release 320, pages 421-430.
Crossref
Yanlong Jia, Chaochao Wang, Jiehua Zheng, Guisen Lin, Dalong Ni, Zhiwei Shen, Baoxuan Huang, Yan Li, Jitian Guan, Weida Hong, Yuanfeng Chen & Renhua Wu. (2019) Novel nanomedicine with a chemical-exchange saturation transfer effect for breast cancer treatment in vivo. Journal of Nanobiotechnology 17:1.
Crossref
Xiuhui Tang, Qing Li, Xiao Liang, Jiebing Yang, Ziling Liu & Quanshun Li. (2019) Inhibition of proliferation and migration of tumor cells through lipoic acid-modified oligoethylenimine-mediated p53 gene delivery. New Journal of Chemistry 43:6, pages 2758-2765.
Crossref
Zhaoxin Gu, Xiuxiu Wang, Ru Cheng, Liang Cheng & Zhiyuan Zhong. (2018) Hyaluronic acid shell and disulfide-crosslinked core micelles for in vivo targeted delivery of bortezomib for the treatment of multiple myeloma. Acta Biomaterialia 80, pages 288-295.
Crossref
Jana S. Miles, Samantha J. Sojourner, Aurellia M. Whitmore, Devon Freeny, Selina Darling-Reed & Hernan Flores-Rozas. (2018) Synergistic Effect of Endogenous and Exogenous Aldehydes on Doxorubicin Toxicity in Yeast. BioMed Research International 2018, pages 1-11.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.